These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 22383583)
1. Low-dose fluvastatin reverses the hypoxic pulmonary adventitial fibroblast phenotype in experimental pulmonary hypertension. Carlin CM; Celnik DF; Pak O; Wadsworth R; Peacock AJ; Welsh DJ Am J Respir Cell Mol Biol; 2012 Aug; 47(2):140-8. PubMed ID: 22383583 [TBL] [Abstract][Full Text] [Related]
2. Fluvastatin inhibits hypoxic proliferation and p38 MAPK activity in pulmonary artery fibroblasts. Carlin CM; Peacock AJ; Welsh DJ Am J Respir Cell Mol Biol; 2007 Oct; 37(4):447-56. PubMed ID: 17556673 [TBL] [Abstract][Full Text] [Related]
3. Fluvastatin prevents vascular hyperplasia by inhibiting phenotype modulation and proliferation through extracellular signal-regulated kinase 1 and 2 and p38 mitogen-activated protein kinase inactivation in organ-cultured artery. Sakamoto K; Murata T; Chuma H; Hori M; Ozaki H Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):327-33. PubMed ID: 15591221 [TBL] [Abstract][Full Text] [Related]
4. Danshensu prevents hypoxic pulmonary hypertension in rats by inhibiting the proliferation of pulmonary artery smooth muscle cells via TGF-β-smad3-associated pathway. Zhang N; Dong M; Luo Y; Zhao F; Li Y Eur J Pharmacol; 2018 Feb; 820():1-7. PubMed ID: 29221952 [TBL] [Abstract][Full Text] [Related]
5. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension. Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871 [TBL] [Abstract][Full Text] [Related]
7. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment. Veith C; Zakrzewicz D; Dahal BK; Bálint Z; Murmann K; Wygrecka M; Seeger W; Schermuly RT; Weissmann N; Kwapiszewska G Thromb Haemost; 2014 Dec; 112(6):1288-303. PubMed ID: 25231004 [TBL] [Abstract][Full Text] [Related]
8. Baicalin inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via the AKT/HIF-1α/p27-associated pathway. Zhang L; Pu Z; Wang J; Zhang Z; Hu D; Wang J Int J Mol Sci; 2014 May; 15(5):8153-68. PubMed ID: 24821539 [TBL] [Abstract][Full Text] [Related]
9. p38 MAP kinase: essential role in hypoxia-mediated human pulmonary artery fibroblast proliferation. Mortimer HJ; Peacock AJ; Kirk A; Welsh DJ Pulm Pharmacol Ther; 2007; 20(6):718-25. PubMed ID: 17055760 [TBL] [Abstract][Full Text] [Related]
10. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation. Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454 [TBL] [Abstract][Full Text] [Related]
11. Reoxygenation Reverses Hypoxic Pulmonary Arterial Remodeling by Inducing Smooth Muscle Cell Apoptosis via Reactive Oxygen Species-Mediated Mitochondrial Dysfunction. Chen J; Wang YX; Dong MQ; Zhang B; Luo Y; Niu W; Li ZC J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645933 [TBL] [Abstract][Full Text] [Related]
12. Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells. Xia S; Tai X; Wang Y; An X; Qian G; Dong J; Wang X; Sha B; Wang D; Murthi P; Kalionis B; Wang X; Bai C Am J Respir Cell Mol Biol; 2011 Jan; 44(1):66-73. PubMed ID: 20160044 [TBL] [Abstract][Full Text] [Related]
13. Proliferation and signaling in fibroblasts: role of 5-hydroxytryptamine2A receptor and transporter. Welsh DJ; Harnett M; MacLean M; Peacock AJ Am J Respir Crit Care Med; 2004 Aug; 170(3):252-9. PubMed ID: 15087293 [TBL] [Abstract][Full Text] [Related]
15. Notch4 mediates vascular remodeling via ERK/JNK/P38 MAPK signaling pathways in hypoxic pulmonary hypertension. Guo M; Zhang M; Cao X; Fang X; Li K; Qin L; He Y; Zhao J; Xu Y; Liu X; Li X Respir Res; 2022 Jan; 23(1):6. PubMed ID: 35016680 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological activation of PPARγ inhibits hypoxia-induced proliferation through a caveolin-1-targeted and -dependent mechanism in PASMCs. Yang K; Zhao M; Huang J; Zhang C; Zheng Q; Chen Y; Jiang H; Lu W; Wang J Am J Physiol Cell Physiol; 2018 Apr; 314(4):C428-C438. PubMed ID: 29351409 [TBL] [Abstract][Full Text] [Related]
17. Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension. Anwar A; Li M; Frid MG; Kumar B; Gerasimovskaya EV; Riddle SR; McKeon BA; Thukaram R; Meyrick BO; Fini MA; Stenmark KR Am J Physiol Lung Cell Mol Physiol; 2012 Jul; 303(1):L1-L11. PubMed ID: 22582113 [TBL] [Abstract][Full Text] [Related]
18. TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells. McGillicuddy FC; O'Toole D; Hickey JA; Gallagher WM; Dawson KA; Keenan AK Vascul Pharmacol; 2006 Jun; 44(6):469-75. PubMed ID: 16624629 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension. Takahashi H; Goto N; Kojima Y; Tsuda Y; Morio Y; Muramatsu M; Fukuchi Y Am J Physiol Lung Cell Mol Physiol; 2006 Mar; 290(3):L450-8. PubMed ID: 16361357 [TBL] [Abstract][Full Text] [Related]
20. Sodium tanshinone IIA sulfonate inhibits hypoxia-induced enhancement of SOCE in pulmonary arterial smooth muscle cells via the PKG-PPAR-γ signaling axis. Jiang Q; Lu W; Yang K; Hadadi C; Fu X; Chen Y; Yun X; Zhang J; Li M; Xu L; Tang H; Yuan JX; Wang J; Sun D Am J Physiol Cell Physiol; 2016 Jul; 311(1):C136-49. PubMed ID: 27194472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]